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Introduction
The ability of macrophages to engulf large (>0.5 µm) particu-
late targets by phagocytosis is central to both the innate and 
adaptive immune responses (Greenberg and Grinstein, 2002). 
Phagocytosis is initiated upon ligation of surface receptors like 
the widely studied Fc receptor (FcR), which recognizes the 
Fc region of IgG to trigger internalization of opsonized matter, 
such as pathogenic microbes. Engagement of FcRs elicits   
tyrosine phosphorylation-dependent signaling events that cause 
profound cellular changes characterized by coordinated actin 
polymerization, the elaboration of pseudopods, and ultimately 
the ingestion of the target into a membrane-bound vacuole termed 
the phagosome (Flannagan et al., 2009).
Much has been learned about the signals that lead to   
actin remodelling. Generation of phosphatidylinositol 3,4,5- 
trisphosphate (PI(3,4,5)P3) and metabolism of phosphatidyl-
inositol 4,5-bisphosphate (PI(4,5)P2) are critical early events 
(Botelho et al., 2000; Marshall et al., 2001; Scott et al., 2005).   
In addition, tyrosine phosphorylation triggers the activation of 
Rac and Cdc42, which direct actin polymerization via SCAR/
WAVE, WASP, and Arp2/3 (May et al., 2000; Hoppe and Swanson, 
2004). By contrast, much less is known about the early events 
that dictate the binding of the phagocytic target. It has been   
tacitly assumed that particle binding is a passive event, driven by 
lateral diffusion of the FcRs in the plane of the plasma mem-
brane (Michl et al., 1983). In accordance with this model, treatment 
of macrophages with jasplakinolide, an F-actin–stabilizing agent, 
greatly reduced particle binding, ostensibly by limiting the lateral 
mobility of the receptors (Mao et al., 2009). A similar explanation 
was offered to account for the effect of 4-phosphatidylinositol   
5-kinase gamma (PIP5K) deletion, which also impaired particle 
attachment (Mao et al., 2009).
In this manuscript we used single-particle tracking (SPT) 
to test experimentally the assumption that FcRs diffuse freely 
in the fluid mosaic of the plasma membrane and that F-actin 
B
inding of ligands by immunoreceptors is thought   
to be a passive, stochastic process. Contrary to this 
notion, we found that binding of IgG-opsonized 
particles by Fc receptors was inhibited in macrophages, 
dendritic and microglial cells by agents that interfere with 
actin assembly or disassembly. Changes in the lateral 
mobility of the receptors—assessed by single-particle 
tracking—or in the microelasticity of the membrane— 
determined by atomic-force microscopy—could not ac-
count for the effects of actin disruption on particle binding. 
Instead, we found that the macrophages contact their   
targets by actively extending actin-rich structures. Forma-
tion of these protrusions is driven by Rac and requires 
phosphatidylinositol 4,5-bisphosphate and phosphatidyl-
inositol 3,4,5-trisphosphate. Capture of C3bi-opsonized 
as well as unopsonized targets by macrophages was also 
dependent on actin. Thus, phagocytes continuously probe 
their environment for foreign particles in a manner akin 
to the constitutive sampling of the fluid milieu by dendritic 
cells. Active probing by phagocytes is most important 
when confronted by scarcely opsonized and/or highly 
mobile targets.
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expression of FcRI, II, and III; neither jasplakinolide alone, 
nor the combined treatment with jasplakinolide and blebbistatin   
altered the density of FcR on the surface of RAW cells (Fig. 1, 
C and D). The ability of the receptors to engage the Fc portion 
of IgG was similarly unaffected. This was verified by measuring 
the ability of the cells to bind soluble IgG aggregates (agIgG). Such 
experiments, which were performed at 15°C to prevent endo-
cytosis, demonstrated that agIgG bound to a similar extent to   
control and jasplakinolide- or jasplakinolide plus blebbistatin– 
treated cells (Fig. 1, E and F). Furthermore, analysis by immuno-
blotting revealed that, irrespective of drug treatment, binding of 
agIgG increased the abundance of tyrosine-phosphorylated 
proteins to a similar degree (not depicted). Together, these ex-
periments indicate that jasplakinolide affects neither the num-
ber of surface receptors, nor their ability to bind IgG.
Next we hypothesized that jasplakinolide inhibits particle 
binding by restricting the lateral mobility of FcRs, thereby pre-
venting their coalescence into high avidity clusters. Single-particle 
tracking (SPT) was used to analyze the mobility of individual 
receptors in the plane of the membrane. To avoid cross-linking, 
we generated antigen-binding fragments (Fab) from the 2.4G2 
primary antibody, which were in turn labeled with biotinylated 
secondary Fab fragments coupled to Quantum dots. Preliminary 
experiments demonstrated that the 2.4G2 Fab fragments retained 
specificity for FcRII/III and that under the conditions used,   
single receptors and not higher order complexes, were tracked 
(Fig. S1, A and B). This system was used to test the notion that 
FcRs diffuse freely on the plane of the membrane and that stiff-
ening the submembranous F-actin network with jasplakinolide 
reduces their mobility. As shown in Fig. 2, these predictions 
were not borne out by the measurements. First, even in untreated 
cells a large fraction (71.2%) of the FcRII/III demonstrated re-
stricted diffusion (Fig. 2, A and B), moving within a confinement 
area of 0.11 µm
2. The diffusion coefficient of the particles dis-
playing confined diffusion was significantly smaller than that of 
particles diffusing in an unrestricted manner (Fig. 2 D). More 
importantly, treatment with jasplakinolide, whether with or with-
out blebbistatin, had little effect on the fraction of restricted   
versus unrestricted receptors (Fig. 2 B) and a modest effect on the 
diffusion coefficient. In fact, the diffusion coefficient increased 
in the presence of jasplakinolide, although this change was not 
statistically significant (Fig. 2 D).
The mobility of the high affinity receptor, FcRI, was also 
analyzed by SPT. Because the affinity of Fab fragments gener-
ated from FcRI-specific antibodies was insufficient for proper 
labeling, intact antibodies were used for these experiments.   
Although dimers may have formed upon addition of the antibodies, 
the labeling procedure did not induce receptor internalization 
because >98% of the probe was removed by an acute acid wash 
at the end of the experiment. As found for FcRII/III, a sizable 
fraction of FcRI diffused in a restricted manner within con-
finement areas and this feature was unaffected by jasplakinolide 
(Fig. 2 C). Similarly, the actin-stabilizing agent had little effect 
on the diffusion coefficient of either the restricted or unrestricted 
FcRI receptors (Fig. 2 D). Therefore, the inhibitory effects of 
jasplakinolide on particle binding cannot be simply accounted 
for by altered FcR mobility in the plane of the membrane.
stabilization  limits  their  mobility,  thereby  curtailing  particle 
binding. Our results are inconsistent with this model and re-
vealed instead that actin-driven active “probing” of the environ-
ment by the cells in a direction perpendicular to the plane of 
the membrane is critical to secure targets to the surface of the 
phagocyte. This unappreciated behavior is in part regulated by 
Rac, PI(4,5)P2, and PI(3,4,5)P3, all of which are required for 
optimal binding.
Results
Actin perturbation impairs the capture of 
IgG-opsonized phagocytic targets
To verify the effect of increased actin polymerization on particle 
binding  we  treated  RAW264.7  macrophages  (called  RAW   
hereafter)  with  jasplakinolide  before  the  addition  of  IgG- 
opsonized latex beads. As reported (Mao et al., 2009), jasplakino-
lide drastically reduced the number of particles associated with 
the macrophages (78% inhibition; Fig. 1 B). However, micro-
scopic visualization of the cells revealed that the drug induced 
gross morphological changes, notably the emergence of large 
membrane blebs (Fig. 1 A). The drastic change in cell shape may 
have altered the ability of the receptors to interact with their tar-
gets. We hypothesized that blebbing resulted from the contrac-
tion of stabilized F-actin filaments, a process likely driven by 
myosin II. We therefore tested the effect of blebbistatin, a selec-
tive myosin IIa inhibitor (Kovács et al., 2004). By itself blebbi-
statin had only modest effects on cell shape but, remarkably, it 
eliminated the blebbing caused by jasplakinolide (Fig. 1 A).   
In parallel, blebbistatin prevented the submembranous compac-
tion of actin caused by jasplakinolide, as revealed by visualiza-
tion of GFP-actin in stably transfected cells (Fig. 1 A, bottom 
panels). Under these conditions jasplakinolide still bound to   
F-actin, as judged by its ability to prevent the binding of labeled 
phalloidin (not depicted). These observations confirmed that   
myosin-induced contraction is required for the blebbing caused 
by jasplakinolide and, more importantly, provided a means of 
testing the effects of actin stabilization on particle binding, un-
contaminated by untoward shape changes. Although blebbistatin 
restored  the  normal  shape  of  jasplakinolide-treated  cells,  it 
failed to prevent the inhibition of particle binding (Fig. 1 B). 
Therefore, impairment of binding was caused by stabilization of 
F-actin, independently of the blebbing that accompanies actin 
compaction when myosin is functional.
Altered behavior of Fc receptors does  
not explain jasplakinolide-induced  
binding defects
The comparatively low affinity of FcR for the Fc portion of 
IgG requires the formation of multiple receptor–ligand com-
plexes to provide sufficient avidity to secure a target particle to 
the macrophage surface. The reduced binding of IgG-coated 
targets caused by jasplakinolide can therefore be envisaged to 
result from impaired lateral mobility of FcR or, more simply, 
from reduced receptor density at the membrane that may have 
resulted from endocytosis or shedding. We used receptor- 
specific antibodies and flow cytometry to quantify the surface 1207 Dynamic capture of phagocytic targets by macrophages • Flannagan et al.
Figure 1.  Actin-perturbing drugs alter the binding of IgG-opsonized particles. (A) Representative differential interference contrast (DIC, top panels) and 
spinning-disk confocal fluorescence images (bottom panels) of RAW cells stably expressing actin-GFP. Where indicated the cells were treated with 1 µM 
jasplakinolide, 0.2 µM latrunculin, and/or 60 µM blebbistatin. DMSO was used as vehicle. Bars: 8 µm (top panels), 17 µm (bottom panels). (B) Quantita-
tion of the effect of actin-perturbing drugs on particle binding. Data are presented as a binding index (see Materials and methods) normalized to the vehicle 
control and are means ± SEM of three experiments, each counting at least 150 macrophages per condition. (C and D) Surface expression of FcRII/III (C) 
and FcRI (D), measured by flow cytometry after pretreatment with actin-perturbing agents or vehicle only. (E) Binding of soluble IgG aggregates to RAW 
macrophages at 15°C. Representative xy and xz optical slices obtained by spinning-disk microscopy are illustrated; bar, 17 µm. Surface-associated IgG 
aggregates were detected using a Cy3-conjugated secondary antibody. (F) Quantification of surface-associated IgG in cells treated with actin-perturbing 
agents. Following labeling as in E, the cells were detached from the substratum, fixed, and analyzed by flow cytometry. Histograms in C–E are representa-
tive of two independent experiments of each type.JCB • VOLUME 191 • NUMBER 6 • 2010   1208
when applying force on the dorsal surface of the cells indicated 
that, as in other cells, jasplakinolide increases membrane rigid-
ity in macrophages (Fig. 3, A and B).
The increased rigidity caused by jasplakinolide could in 
principle account for the impaired ability of the macrophages to 
engage a sufficient number of receptors to secure their targets. 
If correct, this notion predicts that opposite effects should be 
obtained when membrane rigidity is decreased. This prediction 
was tested using latrunculin B, an effective actin-depolymerizing 
agent. We used only short (8 min) latrunculin treatments that 
yield incomplete depolymerization of the submembranous actin 
to limit extreme changes in shape and detachment of the cells 
from the substratum (Fig. 3 C). As illustrated in Fig. 3 C, cells 
treated with the actin-depolymerizing drug underwent visible 
Plasma membrane microelasticity and its 
effect on the binding of phagocytic targets
Because neither the density, mobility, nor the ability of FcR to 
recognize ligands explained the inhibitory effects of jasplakino-
lide, we wondered whether the drug acts by altering the bio-
physical properties of the plasma membrane. Specifically, we 
questioned whether increased rigidity prevents the phagocyte 
membrane from effectively apposing the target particle, which 
is likely required to enable a sufficient number of receptors to 
contact their ligand. Indeed, in other cell types jasplakinolide 
has been shown to reduce the microelasticity of the plasma 
membrane (Sheikh et al., 1997). We used atomic force micros-
copy (AFM) to test whether the F-actin stabilizer exerts a com-
parable effect on macrophages. Measurements of tip deflection 
Figure 2.  Effect of actin perturbation on the mobility of mouse FcR, determined by single-particle tracking (SPT). (A) Representative tracks of FcRII/III, 
labeled under control conditions using primary Fab fragments and detected with quantum dots, as described in Materials and methods. All tracks were 
obtained from ≥20-s movies with an image acquisition rate of 33 Hz. The motion type was determined by moment scaling spectrum analysis and only tracks 
of at least 20 frames were analyzed (see Materials and methods). The cyan lines in A indicate tracks of FcR with unrestricted diffusion, whereas the pink 
lines indicate tracks classified as restricted by the SPT software. The black lines in A indicate the closing of gaps as performed by the SPT software. Tracking 
of receptors in jasplakinolide-treated cells was limited to areas of the plasma membrane devoid of blebs. (B and C) Percentage of FcRII/III (B) and FcRI 
(C) tracked receptors undergoing either restricted or unrestricted diffusion under control or drug-treated conditions. (D) Summary of the calculated diffusion 
coefficients for FcRI and FcRII/III tracked in macrophages pretreated with vehicle (DMSO) or actin-perturbing agents. Data in B–D are means ± SEM of 
three independent experiments, with at least 10 cells analyzed per condition per experiment.1209 Dynamic capture of phagocytic targets by macrophages • Flannagan et al.
(Fig. S3 C). A reproducible and significant increase in the diffu-
sion coefficients of FcRII/III was also recorded (Fig. S3 C), 
though the ratio of confined to freely mobile receptors was not al-
tered when using 2 µM latrunculin B for 8 min (Fig. S3 A), likely 
because the mild conditions used resulted only in partial actin dis-
ruption. Accordingly, more rigorous treatment with latrunculin 
(4 µM for 20 min) reduced the fraction of FcRII/III diffusing in 
a restricted manner, while concomitantly increasing the fraction 
displaying unrestricted diffusion, although these changes did not 
reach statistical significance (Fig. S3 A). These observations dem-
onstrate that the diffusion of FcR is influenced by actin, though 
other factors, such as plasma membrane protein density, likely 
also limit receptor mobility (Frick et al., 2007). Regardless of their 
magnitude, the changes in receptor mobility failed to account for 
the profound inhibition of binding caused by latrunculin.
morphological changes and, as anticipated, their rigidity mea-
sured by AFM decreased (Fig. 3, A and B). Contrary to expecta-
tions, however, the ability of latrunculin-treated cells to bind 
IgG-opsonized latex beads decreased greatly, despite their more 
flexible membrane (Fig. 3 D). Flow cytometry and immuno-
blotting experiments like those described above confirmed that 
the number of FcRs at the surface and their ability to bind and 
be stimulated by soluble agIgG remained unaltered in latrunculin- 
treated cells (Fig. S2; and unpublished data).
The mobility of FcR in cells treated with latrunculin was 
also analyzed, using SPT. Analysis of FcRI revealed a 15% de-
crease in the fraction of diffusion-restricted receptors, with a 
concomitant increase in freely diffusible ones (Fig. S3 B). The 
diffusion coefficients of both subpopulations increased, from 
0.0276 and 0.0523 µm
2/s to 0.0384 and 0.0768 µm
2/s, respectively 
Figure 3.  Effect of actin perturbation on membrane microelasticity and ability to capture IgG-opsonized particles. (A and B) The microelasticity of the 
membrane of control or drug-treated RAW cells was assessed by atomic force microscopy. Representative force curves illustrating the deflection of the can-
tilever after contact with the cell surface are shown in A and quantitation of multiple force curves in B. Data in B are mean slopes ± SEM obtained probing 
a minimum of 15 individual cells at 3 distinct sites/cell, from three independent experiments. (C) Representative DIC images depicting the morphology of 
control and latrunculin B–treated RAW macrophages; bar, 18 µm. (D) Quantitation of the effect of latrunculin B on particle binding. Data are presented as 
a binding index normalized to the vehicle control and are means ± SEM of three experiments, each counting at least 150 macrophages per condition.JCB • VOLUME 191 • NUMBER 6 • 2010   1210
proximity to RAW macrophages, without making contact with 
the bulk plasma membrane. At defined time intervals, the posi-
tion of the laser trap was altered and the ability to remove the 
sRBCs from the vicinity of the phagocyte was assessed (Fig. 4 F). 
Importantly, because the targets were positioned at a short dis-
tance (1 µm) away from the membrane surface, the cells could 
make contact with the sRBCs only by extension of membrane 
protrusions. Indeed, thin projections making contact with the 
phagocytic targets often became apparent when attempting   
to remove the sRBCs from control macrophages (Fig. 4 F).   
In every instance, untreated macrophages engaged the sRBCs 
within 30 s with sufficient force to displace them from the opti-
cal trap (Fig. 4 G). In stark contrast, cells treated with either   
latrunculin B or jasplakinolide plus blebbistatin were unable to 
retain the sRBCs, which were successfully removed by the trap 
even after 150 s (Fig. 4 G). Furthermore, sRBCs placed in direct 
contact with the bulk plasma membrane of drug-treated cells 
could be readily removed from cells through manipulation of 
the optical trap, indicating the necessity of this behavior for 
binding (not depicted). These findings indicate that dynamic   
actin-induced  structures  secure  particles  to  the  surface  of 
phagocytes by increasing the strength of the interaction, in all 
likelihood by facilitating the formation of a larger number of   
receptor–ligand complexes.
Membrane protrusions promote the 
capture of diverse phagocytic targets and 
are used by various phagocytic cell types
The inhibitory effects of jasplakinolide and latrunculin on the 
capture of phagocytic targets are not unique to RAW macro-
phages,  nor  are  they  an  exclusive  feature  of  immortalized 
cells in culture. Primary macrophages isolated from the bone 
marrow of mice displayed a similar behavior, with >90% in-
hibition in jasplakinolide- or latrunculin-treated cells com-
pared with untreated controls (Fig. 5 B). Similarly, binding   
of IgG-coated particles was severely impaired (>95%) by   
latrunculin  in  primary  CD11c-positive  dendritic  cells  that 
were primed with lipopolysaccharide to enhance their adher-
ence to glass coverslips (Fig. 5 C; see Materials and methods   
for details). Lastly, microglial (BV2) cells were also tested.   
As shown in Fig. 5 D, actin perturbation depressed particle 
binding by 85% in these cells. Interestingly, stimulation 
with the protein kinase C agonist phorbol 12-myristate 13- 
acetate (PMA; 100 nM for 5 min), which induced the forma-
tion  of  large  dorsal  ruffles  (not  depicted),  enhanced  the 
capacity of BV2 cells to capture IgG-opsonized particles, and 
the additional binding was also ablated by treatment with 
latrunculin B (Fig. 5 D).
To determine whether the formation of membrane protru-
sions was required for the capture of targets bearing ligands 
other than IgG, we tested the effects of latrunculin on the bind-
ing of C3bi-opsonized sRBCs and of unopsonized zymosan by 
RAW macrophages. Pre-treatment with latrunculin drastically 
impaired the capture of C3bi-opsonized sRBCs relative to con-
trol cells (Fig. 5 A). Likewise, treatment with latrunculin also 
depressed the ability of RAW cells to secure unopsonized zy-
mosan, which is mediated by receptors to microbial-associated 
Dynamic membrane protrusions bind 
phagocytic targets
Taken together with the jasplakinolide observations, the effects 
of latrunculin ruled out changes in receptor mobility or in mem-
brane rigidity as the cause of the impaired particle binding in-
duced by interference with normal actin function. Because both 
actin-stabilizing and -depolymerizing drugs impaired particle 
binding, we hypothesized that a dynamic actin-dependent pro-
cess was involved in optimal receptor engagement. Specifically, 
we explored whether FcRs are driven toward their ligands by 
an active process involving actin-mediated protrusion or con-
traction. Light microscopy of RAW cells revealed that the macro-
phages are constitutively active, continuously elaborating and 
retracting ruffles and filopodia (Video 1). Of note, immunolabel-
ing experiments preformed on live cells revealed that FcR is 
present in these dynamic structures at a density comparable   
to that in the bulk plasma membrane (Fig. S4). Because this   
dynamic behavior is ablated by jasplakinolide or latrunculin 
(unpublished data), we considered whether “probing” of the   
environment by these protrusions is involved in optimal FcR 
binding. To quantitatively assess the spontaneous extension of 
protrusions we used total interference reflection fluorescence 
microscopy  (TIR-FM).  Macrophages  stably  transfected  with 
glycophosphatidylinositol (GPI)-linked GFP, where the fluores-
cent protein is exofacial, were suspended and allowed to settle 
onto a BSA-coated coverslip. Extensions of the membrane that 
made contact with or closely approached the coverslip became 
readily apparent by TIR-FM (Fig. 4 A and Video 2). Notably, 
these membrane protrusions repeatedly retracted and reappeared, 
indicating that they are dynamic. Integration of the area engaged 
over time demonstrated that this behavior occurs continuously 
(Fig. 4 B). The extensions are driven by actin remodelling   
because they were largely eliminated by jasplakinolide or   
latrunculin (Fig. 4 B and Video 3).
IgG  was  omitted  from  the  preceding  experiments  to 
demonstrate that the extension of protrusions occurs constitu-
tively, in the absence of phagocytic ligands. When the surface 
of the coverslip was coated with IgG the spontaneous mem-
brane extensions engaged the opsonin but failed to retract,   
resulting in an explosive spreading, a form of “frustrated 
phagocytosis” (Video 4).
Scanning electron microscopy (SEM) was used to better 
visualize the protrusions that are involved in the early stages of 
engagement of phagocytic targets by macrophages. When the 
interaction between cells and IgG-opsonized beads was arrested 
at a very early stage, before development of phagocytic cups, 
the association of fine filopodia and membrane ruffles with the 
targets were readily apparent (Fig. 4, C and D). Of note, even when 
particles settled by gravity onto latrunculin- or jasplakinolide-
treated cells, such attachments were absent (Fig. 4 E). We there-
fore assumed that active probing by actin-induced filopodia and 
ruffles enabled a sufficient number of receptors to become en-
gaged, securing the particles and preventing their removal upon 
subsequent washing. That retentive forces developed as a result 
of the actin-driven protrusions was validated using optical twee-
zers. IgG-opsonized sheep red blood cells (sRBCs), which were 
easily trapped by the laser beam, were positioned and held in 1211 Dynamic capture of phagocytic targets by macrophages • Flannagan et al.
Figure 4.  Detection of dynamic macrophage membrane protrusions and their role in binding phagocytic targets. (A and B) Suspended RAW macrophages 
stably expressing a GPI-linked GFP were treated with actin-perturbing agents or vehicle only (DMSO) and allowed to sediment by gravity onto uncoated 
glass coverslips, while monitoring fluorescence by TIR-FM. Panel A illustrates the behavior of two control cells shortly after making contact with the coverslip 
surface. Arrowheads illustrate contact points not present in previous image, arrows point to sites where contacts visible in previous frame were lost; bar, 7 µm. 
In B, the contact area revealed by TIR-FM in experiments like A is plotted over time for control and drug-treated cells. Data are integrated mean areas ± 
SEM obtained by analyzing at least 10 cells from three independent experiments for each condition. (C–E) Scanning electron micrographs of RAW cells 
exposed briefly (40 s) to IgG-opsonized latex beads. The presence of membrane protrusions making contact with the phagocytic target is evident in control 
(C and D) but not in latrunculin-treated (E) cells; bars: 1 µm (C); 2 µm (D and E). (F and G) Use of laser tweezers to detect capture of particles placed in 
the vicinity of macrophages. IgG-opsonized sheep red blood cells (sRBCs) were trapped by an optical tweezer and placed in proximity to control (T = 0, 
top) or drug-treated cells (T = 0, bottom). The position of the optical trap is indicated by the square brackets. After 60 s (T = 60) the trap was relocated to 
a position away from the cell, as indicated by the brackets. Note that the sRBCs are captured by protrusions on the control cells (arrow), displacing them 
from the trap, but not by the jasplakinolide-treated cells; bar, 8 µm. (G) Quantitative analysis of target capture measured from optical trap experiments like 
that in F. The percentage of phagocytic targets that remained in the optical trap is presented as a function of time. Data are means of a total of 30 trapped 
sRBCs analyzed for each condition tested in three independent experiments.
molecular patterns, such as dectin and mannan receptors (Fig. 5 A; 
Brown and Gordon, 2001). Hence, dynamic actin rearrange-
ments are required for the capture of diverse targets by multiple 
receptors in a variety of phagocytic cells.
The GTPase Rac is required for probing 
and to optimally secure phagocytic targets
The mechanism underlying the extension of the actin-driven 
protrusions that probe for the presence of phagocytic targets JCB • VOLUME 191 • NUMBER 6 • 2010   1212
guanine  nucleotide  dissociation  inhibitor  (GDI),  as  indicated   
by its association with the plasma membrane (Fig. 6 D). Under 
these conditions, Rac1(T17N) markedly reduced particle bind-
ing to the surface of the transfectants (Fig. 6 E). Expression of a 
membrane-targeted GFP (PM-GFP) was without effect on bind-
ing (Fig. 6, D and E), ruling out nonspecific effects of transfec-
tion or of delivery of GFP-tagged proteins to the membrane. 
Moreover, comparable levels of expression of a dominant-negative 
form of another GTPase, Cdc42(T17N), were also without effect 
(Fig. 6 E), arguing in favor of a specific effect of Rac1.
Macrophages respond to macrophage colony-stimulating 
factor (MCSF) with Rac activation (Cox et al., 1997; see also 
Fig.  S5 A).  Because  impairment  of  Rac  diminished  particle 
binding, we anticipated that Rac stimulation would have the op-
posite  effect.  Indeed,  pretreatment  of  the  macrophages  with   
10 ng/ml MCSF for 6 min increased the rate of formation of 
protrusions, as measured by TIR-FM (Video 5) and, more impor-
tantly, enhanced the ability of the cells to bind IgG-coated beads 
by 66.4% (Fig. S5 B). Together these experiments showed that 
Rac is critical to the actin-mediated extension of protrusions 
that trap particles for subsequent phagocytosis.
PI(4,5)P2 and PI(3,4,5)P3 are required for 
optimal target binding
Phosphoinositides are intimately involved in the control of Rho 
GTPases and actin polymerization. We therefore analyzed their 
was studied next. The involvement of Rac was investigated using 
the p21-binding domain (PBD) of PAK, which interacts with the 
active, GTP-bound form of this GTPase. As shown in Fig. 6 A, 
constitutive activity of Rac can be detected in unstimulated cells 
using PAK-PBD. The specificity of the pull-down assay was vali-
dated by pretreating the cells with Clostridium difficile toxin B, 
which  glucosylates  and  inactivates  Rho-family  GTPases  (Just   
et al., 1994). The toxin eliminated the basal Rac activity (Fig. 6 A) 
and also the constitutive extension and retraction of protrusions, 
assessed by TIR-FM of cells transfected with GPI-GFP as above 
(not depicted). In parallel, toxin B profoundly depressed the ability 
of the macrophages to bind IgG-opsonized particles (Fig. 6 B).   
Unlike latrunculin B–treated cells, which show few protrusions 
when analyzed by SEM (Fig. 5 E), cells exposed to toxin B dis-
played ruffles/ridges (Fig. 6 C), yet were unable to secure targets on 
their surface. We believe that this is a consequence of the immobil-
ity of these protrusions, as indicated by the TIR-FM experiments.
Because toxin B inactivates not only Rac but also other 
Rho GTPases, we tested the effects of compound NSC23766, a 
more selective antagonist of Rac1, to better evaluate the contri-
bution of this GTPase. Under the conditions used, NSC23766 
partially inhibited the basal activity of Rac1, as well as particle 
binding (Fig. 6, A and B). To more definitively establish the role 
of Rac in particle capture we transfected cells with a dominant-
negative allele of this GTPase (Rac1(T17N)). The inactive mu-
tant  was  expressed  at  levels  that  exceeded  the  endogenous 
Figure 5.  Dynamic actin is required for the capture of di-
verse  phagocytic  targets  and  is  a  general  requirement  for 
binding by professional phagocytes. (A) Quantitation of the 
ability of RAW macrophages to bind either C3bi-opsonized 
sRBCs or unopsonized zymosan after treatment with latruncu-
lin B or vehicle (DMSO) alone. (B) Effect of actin perturbation 
on the ability of primary bone marrow–derived macrophages 
to  bind  IgG-opsonized  phagocytic  targets.  Primary  macro-
phages  were  isolated  from  the  bone  marrow  of  BALB/c 
mice. A single experiment where 150 macrophages were 
counted per condition is shown. (C) Effect of latrunculin B on 
the capture of IgG-coated latex beads by LPS-stimulated bone   
marrow–derived dendritic cells. Only cells positive for surface 
expression of CD11c, as determined by immunofluorescence, 
were counted. (D) Binding of IgG-opsonized beads to BV2 
microglial cells. Where indicated, the cells were treated with 
PMA (100 nM for 5 min) and/or latrunculin B. A, C, and D 
show means ± SEM of three independent experiments.1213 Dynamic capture of phagocytic targets by macrophages • Flannagan et al.
the cells to engage IgG-coated beads (Fig. 7 B), suggesting that 
PI(4,5)P2 is required for the process. These observations are con-
gruent with the finding by Mao et al. (2009) that PIP5K activity 
is required for macrophages to bind IgG-opsonized targets.
The involvement of PI(3,4,5)P3, which can stimulate Rac 
guanine nucleotide exchange factors (Fleming et al., 2000; Côté 
et al., 2005), was also investigated. To this end RAW macro-
phages were treated with the phosphatidylinositol 3-kinase 
(PI3K) inhibitor LY294002. The effectiveness of the inhibitor 
was validated analyzing cells expressing Akt-PH-RFP, a bio-
sensor for 3-polyphosphoinositides. Although the bulk of the 
probe is soluble in unstimulated cells, a fraction is detectable in 
association with the plasma membrane, particularly at sites 
possible role in the binding of phagocytic particles. Because pro-
longed depletion of PI(4,5)P2 is deleterious to cells, often causing 
their detachment from the substratum, we used a method to more 
acutely and precisely control the concentration of the inositide. 
Cells were transfected with a combination of plasmids that en-
able the rapid recruitment of type IV phosphoinositide-5 phos-
phatase (5-Pase) to the plasmalemma upon addition of rapamycin 
(van Zeijl et al., 2007). Addition of 1 µM rapamycin to such cells 
induced relocalization of the soluble 5-Pase to the membrane 
(Fig. 7 A) and resulted in vigorous hydrolysis of PI(4,5)P2, which 
was verified by monitoring the distribution of PH-PLC-GFP, a 
PI(4,5)P2-specific probe (not depicted). Importantly, recruitment 
of the 5-Pase to the membrane drastically reduced the ability of 
Figure 6.  Effect of impaired Rac activation on phagocytic target binding. (A) Detection of active Rac in untreated (DMSO) and in C. difficile toxin B– or 
NSC23766-treated cells. The presence of Rac-GTP was analyzed by pull-down experiments using PAK-PBD, followed by immunoblotting (top). Total Rac 
in an aliquot of the lysates was also probed by immunoblotting (bottom). The mean normalized ratio of PAK-PBD–bound Rac/total Rac from two indepen-
dent experiments is indicated below the blot. (B) Quantitation of the effect of Rac antagonists on binding of IgG-opsonized beads. Data are presented as 
a binding index normalized to the vehicle control and are means ± SEM of three experiments, each counting at least 150 macrophages per condition. 
(C) Scanning electron micrograph of C. difficile toxin B–treated cells incubated with opsonized beads; bar, 5 µm. (D) Confocal microscopic images of 
RAW macrophages transfected with plasmids encoding either Rac1(T17N)-GFP or a plasma membrane–targeted GFP (PM-GFP). The transfectants were 
exposed to IgG-opsonized beads (blue) to assess binding efficiency; bar, 18 µm. (E) Mean binding index for cells transfected with either Rac1(T17N)-GFP, 
Cdc42(T17N)-GFP, or PM-GFP. Data were normalized to the binding observed in PM-GFP–transfected cells, used as a control, and are means ± SEM of 
three experiments each counting at least 60 cells.JCB • VOLUME 191 • NUMBER 6 • 2010   1214
phagocytic particles requires neither actin polymerization nor 
active signaling. Instead, binding is regarded as a passive event, 
where the engagement of multiple receptors required to provide 
sufficient avidity to retain the particle results from spontaneous 
(Brownian) receptor diffusion in the plane of the membrane. 
According to this model, restricting lateral diffusion of the re-
ceptors would reduce the ability of the cells to engage their tar-
gets. Indeed, Mao et al. (2009) reported that stabilization of the 
actin skeleton with jasplakinolide, a maneuver predicted to re-
duce receptor mobility, impaired particle binding, an observa-
tion that we were able to duplicate (Fig. 1 B).
Although the majority of the reports agree with the pre-
ceding conclusions, some dissenting observations have been 
published. Previously, Herskovitz et al. (1977) reported that   
actin perturbation by cytochalasin treatment of primary human 
mononuclear cells significantly impaired binding of IgG-sensitized 
RBC. Sobota et al. (2005) found that optimal particle binding to 
phagocytes required tyrosine phosphorylation, whereas Dale et al. 
(2009) not only obtained similar results but also reported that 
inhibitors of actin polymerization depressed binding. These ap-
parent discrepancies may be attributable to differences in the 
experimental conditions, particularly the extent of opsonization of 
the target particle. In this regard, Dale et al. (2009) found that the 
sensitivity of binding to cytoskeletal disruption was inversely 
of active membrane protrusion (Fig. 7 C, left). Addition of 
LY294002 caused detachment of Akt-PH-RFP from the mem-
brane and largely eliminated the dynamic extension of mem-
brane protrusions (Fig. 7 C, right; unpublished data). The drug 
also reduced the ability of the cells to retain IgG-opsonized   
latex targets by 62.4% (Fig. 7 D), indicating PI(3,4,5)P3 and/or 
PI(3,4)P2 contribute to their binding.
Discussion
Conventional phagocytosis assays have been optimized to yield 
effective and synchronous engulfment of multiple particles. For 
this purpose large (>3 µm) particles are generally used, which 
are opsonized densely and overlaid (often sedimented by cen-
trifugation) onto adherent phagocytes. Synchronous uptake is 
ensured by sudden warming of the medium, after a lengthy pre-
incubation at 0–4°C. There is general agreement that, under 
these conditions, firm binding of the targets to the surface of the 
phagocytes can be obtained whether in the presence of cytocha-
lasin (Newman et al., 1991), after inhibition of Rac (Cox et al., 
1997; Caron and Hall, 1998), or in cells treated with tyrosine ki-
nase inhibitors or wortmannin (Greenberg et al., 1993; Ninomiya 
et al., 1994; Araki et al., 1996). Such observations led to the 
generally accepted notion that, unlike internalization, binding of 
Figure 7.  Effect of altered phosphoinositide metabolism on the binding of IgG-opsonized targets. (A) RAW macrophages were transfected with plasmids 
expressing a form of human type IV phosphoinositide-5 phosphatase (5-Pase) that is RFP tagged and can be targeted to the membrane upon addition of 
rapamycin (Rap). Shown is the effect of addition of 1 µM Rap or vehicle (DMSO) only on the recruitment of the 5-Pase to the membrane. (B) Binding of 
IgG-opsonized beads to cells transfected with the recruitable 5-Pase after treatment with DMSO or Rap. (C and D) Effect of 100 µM LY294002 on the 
distribution of Akt-PH-RFP (C) and on IgG-coated bead binding (D). The images are representative of four independent experiments; bar, 17 µm. Data in   
B and D are normalized means ± SEM of three independent experiments, each counting the beads bound by 150 macrophages.1215 Dynamic capture of phagocytic targets by macrophages • Flannagan et al.
We found that the extensions are driven at least in part by Rac 
and require both PI(4,5)P2 and PI(3,4,5)P3. Of note, the exten-
sions are formed continuously in synthetic media ostensibly devoid 
of cytokines, growth factors, or other soluble agonists. Inter-
action of integrins with the substratum is also unlikely to be respon-
sible for the spontaneous formation of extensions, which were 
observed by TIR-FM in cells settling onto BSA-coated glass. 
This intrinsic ability of macrophages to probe the environment 
for particulate targets is akin to the continuous sampling of the 
fluid milieu that dendritic cells perform in search for antigenic 
material. It thus appears that a subset of the Rho-family GTPases 
is constitutively activated in myeloid cells, to support their role 
in environmental surveillance.
In summary, we conclude that two distinct stages of the 
phagocytic process require actin polymerization dependent on 
Rho-family GTPases and phosphoinositides: the initial capture 
of the prey and its subsequent internalization. The requirement 
for actin-mediated probing is greatest when sparsely opsonized 
and/or rapidly moving particles are the target, but is obviated 
when heavily opsonized particles are exposed to the phagocyte 
surface for extended periods, enabling passive engagement of 
ligands by receptors. By contrast, the need of the engulfment 
process for actin remodelling is absolute.
Materials and methods
Reagents
Rat anti–mouse FcII/III antibody (clone 2.4G2) was purchased from the 
Sunnybrook  Health  Sciences  Centre  Hybridoma  core  facility.  Rat  anti–
mouse FcRI (clone 290322) and rat isotype control antibodies IgG2a and 
IgG2b were obtained from R&D Systems. The hamster anti–mouse Cd11c 
antibody (clone N418) was from eBioscience. All secondary antibodies 
were from Jackson ImmunoResearch Laboratories, Inc. Streptavidin 655-
Quantum dots were from Invitrogen. Jasplakinolide and LY294002 were 
proportional to opsonin density, an important observation that 
we have replicated (Fig. 8, A and B). Additionally, we found 
that the duration of the coincubation of cells and particles and 
the stringency of the subsequent washing procedure also dictate 
the effect of the inhibitors (Fig. 8, B and C). As mentioned, most 
studies investigating phagocytosis have used lengthy incuba-
tions in the cold, often in combination with centrifugation of 
phagocytic targets onto the cells as a means of synchronizing 
particle engulfment. Presumably, these experimental conditions 
circumvented the  necessity of  dynamic cytoskeletal changes 
that would otherwise be required for target capture. Indeed, in-
cubation of cells at 4°C alone, which inhibits actin dynamics, is 
sufficient  to  impair  particle  binding  very  significantly  when 
short incubations with targets are used (Fig. 8 B). Importantly, 
this impairment can be completely circumvented by mimicking 
the lengthy incubations commonly used in other studies, ex-
plaining why particle capture was incorrectly deemed as a pas-
sive event (Fig. 8, B and C).
The lower opsonin densities and short incubations at 37°C 
used in our studies are much more likely to mimic the physio-
logical situation, where neither the particles nor the phagocytes 
are stationary. Indeed, small pathogens are anticipated to make 
very transient contacts with phagocytes, driven away from the 
surface by thermal or hydrodynamic forces, or propelled by ciliary 
or flagellar motion. In such cases, an effective capture mecha-
nism is required and passive lateral diffusion of receptors is un-
likely to suffice. Our findings indicate that phagocytes improve 
the effectiveness of the binding process by actively probing their 
environment with actin-driven protrusions. Attachment of macro-
phages to target particles by means of thin extensions had   
been reported (Kress et al., 2007), but neither the underlying 
mechanism nor its relevance to particle binding were explored. 
Figure 8.  Effect of temperature and opsonin density on particle binding. (A) Effect of opsonin density on binding in the presence and absence of the 
actin-depolymerizing agent latrunculin B. RAW macrophages were maintained at 37°C and treated with either vehicle control (DMSO, black bars) or 
latrunculin B (2 µM, gray bars) and then exposed to sRBCs for 3 min. The final dilution of the opsonizing IgG used for each condition is indicated below 
the abscissa. The percentages above the bars indicate the reduction in binding induced by latrunculin; data are presented as a binding index normalized 
to DMSO-treated cells. (B) Effect of opsonin density on binding at varying temperatures. RAW macrophages maintained at either 37°C or 4°C (to inhibit 
actin rearrangements) were incubated with IgG-opsonized sRBCs for either 40 s (black and gray bars) or 20 min (white bar) as indicated. The final dilution 
of opsonin used for each condition is indicated below the abscissa. The percentages above the bars indicate the reduction in particle binding induced by 
cooling, relative to control. Data are presented as a binding index normalized to cells maintained at 37°C. (C) RAW macrophages pretreated with latrun-
culin B (gray bars) or with vehicle only (DMSO; black bar) were exposed to IgG-opsonized beads for either 30 s or 30 min, as indicated, before washing. 
Data are means ± SEM of three independent experiments.JCB • VOLUME 191 • NUMBER 6 • 2010   1216
subsequently labeled with DyLight 488–conjugated goat anti–human sec-
ondary antibodies.
Bright-field and fluorescence microscopy
Differential interference contrast (DIC) images were acquired using a micro-
scope (DMIRE2; Leica) outfitted with 63x or 100x oil immersion objectives. 
Fluorescence images were acquired using spinning-disk confocal micros-
copy. The spinning-disk confocal systems (Quorum Technologies) used in our 
laboratory are based on an Axiovert 200M microscope (Carl Zeiss, Inc.) 
with 63x (NA 1.4) or 100x (NA 1.45) oil immersion objectives, equipped 
with diode-pumped solid-state lasers (440, 491, 561, 638, and 655 nm; 
Spectral Applied Research) and a motorized XY stage (Applied Scientific   
Instrumentation). Images were acquired using back-thinned, electron-multiplied 
(model C9100-13 ImagEM; Hamamatsu Photonics) or conventional cooled 
charge-coupled  device  (model  C4742-95-12ER;  Hamamatsu  Photonics) 
cameras controlled by Volocity software 4.1.1 (PerkinElmer).
Fab fragment preparation
To digest anti-FcR antibodies, immobilized papain (Thermo Fisher Scien-
tific) was used as described in the manufacturer’s protocol. Fab fragments 
were purified by FPLC using a Sephacryl S100 column. Fab-enriched frac-
tions free of Fc fragments were isolated after identification by nonreducing 
SDS-PAGE and Western blot analysis.
Receptor labeling, single-particle tracking, and diffusion analysis
RAW cells cultured on a coverslip were blocked for 5 min in blocking me-
dium (HPMI, 5% [vol/vol] goat serum). To label FcRII/III, primary Fab 
fragments derived from clone 2.4G2 were diluted in blocking medium and 
incubated with cells for 10 min. Next, a biotinylated secondary Fab frag-
ment diluted to 0.75 µg/ml was added for 8 min. The above steps were 
performed with medium warmed to 37°C. After washing with cold PBS, 
streptavidin-conjugated 655-Qdots diluted in PBS with 5% (vol/vol) goat 
serum were added for 5 min at 4°C. The coverslip was then washed with 
ice-cold HPMI containing 0.2 µg/ml biotin, to block any unengaged strep-
tavidin. Coverslips were then transferred to a Leiden chamber with warm 
HPMI and the chamber placed on a heated stage on a microscope (Axio-
vert 200M; Carl Zeiss, Inc.) equipped with a custom 2.5x lens and a 100x 
(NA 1.45) objective. Movies of individual cells were acquired using Volocity 
software at a frame rate of 33.3 Hz by epifluorescence microscopy. The 
imaged receptors were detected and tracked as described in Jaqaman   
et  al.  (2008).  In  brief,  particle  positions  and  intensities—which  were   
sub-resolution features—were estimated by (i) detecting significant local   
intensity maxima and (ii) fitting Gaussian kernels approximating the two- 
dimensional point spread function of the microscope.
Receptor  diffusion  types  were  extracted  using  a  moment  scaling 
spectrum (MSS) analysis of receptor displacements (Ferrari et al., 2001; 
Ewers et al., 2005): (i) For each time shift , the 0th to 6th displacement 
moments, 0() to 6(), were calculated (note that the commonly used 




m   
 ( ) = 4 	
for m = 0…6, describing how each moment scaled with time shift , the 
generalized diffusion coefficient Dm and power m were estimated. In the 
commonly used MSD analysis, the power 2 = 1 for unconfined diffusion. 
The second moment yielded the “normal” diffusion coefficient D2. (iii) The 
plot of m versus m is called the moment scaling spectrum. For a strongly 
self-similar process, it follows a straight line, the slope of which indicates 
the type of motion underlying the analyzed trajectory: a slope of 0.5   
implies normal diffusion, a slope <0.5 indicates confined diffusion, and a 
slope >0.5 indicates super-diffusion.
Because of the finite length of receptor trajectories, however, 0.5 
could not be used as the cut-off between the different motion types. Instead, 
trajectory length-dependent confined diffusion and super-diffusion cut-offs 
were calculated to ensure 95% confidence in the classification. To deter-
mine  the  cut-offs  as  functions  of  trajectory  length,  1,000  2D-simulated 
Brownian trajectories at every length (20–500 frames) were subjected to 
the MSS analysis, yielding a distribution of MSS line slopes for every 
length. The length-dependent confined diffusion cut-offs were then taken as 
the 2.5th percentile of the distributions, whereas the super-diffusion cut-offs 
were taken as the 97.5th percentile. Trajectories shorter than 20 frames 
were too short to analyze and classify, whereas for trajectories longer than 
500 frames the cut-offs were approximated by the cut-off value at 500 frames. 
These thresholds were independent of the Brownian motion diffusion 
purchased from Enzo Life Sciences, Inc. and EMD, respectively. Blebbi-
statin, latrunculin B, and other reagents were purchased from Sigma- 
Aldrich. All tissue culture supplies were from Wisent, Inc.
Tissue culture and transient transfection
RAW264.7 murine macrophages obtained from the American Type Culture 
Collection were maintained in DME or RPMI 1640 with 5% (vol/vol) fetal 
bovine serum at 37°C in a 5% CO2 incubator. For live-cell imaging or incu-
bations in the absence of CO2, Hepes-buffered RPMI (HPMI) medium was 
used. BV2 microglial cells, a gift from T. Trang (The Hospital for Sick Chil-
dren, Toronto, Ontario, Canada) were similarly maintained. Primary bone 
marrow–derived dendritic cells were isolated from 13-wk-old C57B6 mice 
and cultured in RPMI supplemented with 10% FCS and 10 ng/ml GM-CSF 
for 8 to 12 d. Dendritic cells were identified by CD11c immunoreactivity.
Transfections were performed using FuGene HD (Roche) transfection 
reagent according to the manufacturer’s protocol. Routinely a total of 2–4 µg 
of plasmid DNA with 5 µl of transfection reagent was added to each well 
of a 12-well tissue culture plate and incubated 18–24 h before use. The 
plasmids used in this study were GPI-GFP (Nichols et al., 2001), PM-GFP 
(Teruel et al., 1999), Rac(T17N)-GFP and Cdc42(T17N)-GFP (generous 
gifts from the late Dr. Gary Bokoch, Scripps Research Institute, La Jolla, 
CA), PH-PLC-GFP (Várnai and Balla, 1998), Akt-PH-RFP (cloned as de-
scribed [Haugh et al., 2000] and fused to RFP), and PM-FRB-CFP and 
FKB12-RFP-5pase (van Zeijl et al., 2007).
Pharmacological treatments
Jasplakinolide, blebbistatin, and latrunculin B were used at a final concen-
tration of 1, 60, and 2 µM or 4 µM, respectively. The drugs were added 
for the indicated period before and also during the experimental measure-
ment. Blebbistatin was added 20 min before the addition of jasplakinolide. 
Treatment with Clostridium difficile toxin B was for 3–4 h at 50 ng/ml. 
NSC23766 treatment was at 500 µg/ml for 18–24 h before experimenta-
tion. LY294002 was used at 100 µM. Dendritic cells were treated over-
night  with  50  ng/ml  lipopolysaccharide  (Sigma-Aldrich)  to  promote 
adherence to glass and phagocytic activity.
Binding and phagocytosis assays
Latex beads (3.87-µm diameter; Bangs Laboratories, Inc.) were opsonized 
with human IgG (3 mg/ml) for at least 1 h. Sheep red blood cells (sRBCs) 
were opsonized with rabbit anti–sheep IgG by mixing sRBCs with different 
dilutions of opsonin in PBS at room temperature as described previously 
(Vieira et al., 2001). Alternatively, sRBCs were opsonized with C3bi as 
described  previously  (Jongstra-Bilen  et  al.,  2003),  and  were  added  to   
serum-starved cells pretreated with 100 nM phorbol 12-myristate 13-acetate 
(PMA) to activate CR3 receptors. In brief, sRBCs were opsonized with sub-
agglutinating concentrations of rabbit anti–sheep IgM in PBS supplemented 
with 0.5 mM MgCl2 and 0.5 mM CaCl2 (PBS
2+) for 1 h at room tempera-
ture. After washing twice with PBS
2+, sRBCs were incubated with C5-deficient 
serum (Sigma-Aldrich) for 20 min at 37°C with constant mixing to opsonize 
with C3bi. Opsonized sRBCs were subsequently washed with PBS
2+ and 
used immediately. Unopsonized Alexa 455–labeled zymosan, a gift from 
Dr. G.D. Fairn (The Hospital for Sick Children, Toronto, Ontario, Canada), 
was used at a final concentration of 20 µg/ml. For binding experiments, 
phagocytic targets were added to individual wells of a 12-well tissue cul-
ture plate, centrifuged for 15 s at 277 g, and then incubated at 37°C for 
35 s before 5 vigorous washes with ice-cold PBS. Cells were then fixed 
with 4% (vol/vol) paraformaldehyde or ice-cold methanol, as appropriate. 
To calculate the binding index (i.e., the number of bound beads/number of 
cells), at least 150 macrophages were counted per condition. To facilitate 
comparison, the experimental data were normalized to the binding index 
of the control within each experiment, which was designated as 100%.
Aggregated IgG (agIgG) was generated and used as described 
previously (Mero et al., 2006), except that incubation with the cells was at 
15°C and quantification of binding was performed by flow cytometry.
Flow cytometry
While  adherent,  macrophages  were  labeled  with  anti-FcRII/III  (clone 
2.4G2) or an irrelevant isotype (IgG2b)-matched control at 10 µg/ml. 
Bound primary antibody was detected using DyLight 488–conjugated don-
key anti–rat secondary antibody. For the detection of FcRI, rat anti–mouse 
FcRI (clone 290322) or isotype (IgG2a)-matched control antibodies were 
used at 5 µg/ml. Receptor expression was quantified using a FACScalibur 
(Becton Dickinson) flow cytometer and background fluorescence was cor-
rected using blebbistatin-treated RAW cells alone. In some experiments   
primary antibody was substituted for soluble aggregated IgG that was   1217 Dynamic capture of phagocytic targets by macrophages • Flannagan et al.
Active Rac determinations
GTP-bound Rac was isolated using GST-PAK-PBD bound to glutathione- 
derivatized beads, as described previously (Di Ciano et al., 2002). In brief, 
bacteria expressing recombinant GST-PAK-PBD were lysed in STE buffer 
(10 mM Tris, 150 mM NaCl, and 1 mM EDTA, pH 8.0) using a French 
Press. After centrifugation the supernatant was collected, Triton X-100 was 
added (1% [vol/vol] final concentration), and this mixture was incubated 
with glutathione-Sepharose beads (GE Healthcare) to bind GST-PAK-PBD. 
To pull down active Rac, cells were lysed in MLB buffer (25 mM Hepes, 
150 mM NaCl, 1% [vol/vol] Igepal, 10 mM MgCl2, 1 mM EDTA, and 
10% [vol/vol] glycerol, pH 7.5) containing protease inhibitors and the cell 
lysates were incubated with PAK-PBD–bound beads at 4°C for 1 h with 
mixing. Total levels of Rac (determined from whole-cell lysates) and GTP-
bound Rac (determined from bead slurries) were analyzed by immunoblot 
using the anti-Rac monoclonal antibody 23A8 (Millipore).
Use of laser tweezers to monitor particle binding
Sheep red blood cells (sRBCs) were opsonized as described previously 
(Vieira et al., 2001) and added to coverslips with adherent RAW cells.   
Individual sRBCs, which were more easily trapped than latex beads, were 
captured in an optical trap using a laser tweezer system (3W Nd:Yag infra-
red laser; Molecular Machines & Industries) installed on a microscope   
(Axiovert 200M; Carl Zeiss, Inc.) with a 100x objective (NA 1.4). Trapped 
sRBCs were held by the laser tweezer in the vicinity (1 µm) of the cell sur-
face and the ability of the cell to capture the phagocytic target with a force 
exceeding that of the optical trap was measured over time.
Statistical analyses
Statistical parameters were determined using Prism 5 software (GraphPad Soft-
ware, Inc.). Significance of differences was calculated using paired t tests.
Online supplemental material
Fig. S1 shows the specificity of the purified 2.4G2 Fab fragment and its 
ability to label monomeric FcRII/III. Fig. S2 shows the effect of actin de-
polymerization on surface expression of FcR. Fig. S3 shows SPT analysis 
of the effect of actin depolymerization on the mobility of FcR. Fig. S4 shows 
the localization of FcRII/III to membrane ruffles and filopodia. Fig. S5 illus-
trates the effect of MCSF on actin and particle binding. Video 1 shows the   
dynamic behavior of RAW macrophages. Video 2 shows the constitutive 
probing behavior of RAW macrophages expressing a GPI-GFP. Video 3 dem-
onstrates the effects of latrunculin B on the probing behavior of RAW macro-
phages expressing GPI-GFP. Video 4 shows the rapid onset of frustrated 
phagocytosis as a GPI-GFP–expressing RAW macrophage contacts an IgG-
opsonized coverslip. Video 5 demonstrates the effect of MCSF on the probing 
behavior of GPI-GFP–expressing RAW cells.
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coefficient, as verified by performing two separate simulations with differ-
ent diffusion coefficients (1 and 0.1 pixels
2/unit time).
The confinement radius of receptors undergoing confined diffusion 
was derived from the scatter of positions along each trajectory. In particu-
lar, an eigenvalue decomposition of the variance–covariance matrix of the 
positions was performed, from which the positional standard deviation 
was calculated as
	
2 2 2   + ( ) / 	
(1 and 2 are the two eigenvalues). Assuming that receptor motion in-
side the confinement area was a random walk, in which case a receptor 
would visit every position inside its confinement region with uniform 
probability (Dorn et al., 2005), the confinement radius R was then cal-
culated as
	 R = + 2 2 2 2 x   / . 	
The detected particles were tracked using a 2-step single-particle tracking 
algorithm that could follow dense receptor fields and generate complete 
trajectories by closing gaps and capturing merging and splitting events.   
In the first step, the algorithm linked particles between consecutive frames, 
seeking a robust, spatially global solution. However, the tracks generated 
in the first step started and ended not only because of true particle appear-
ance  and  disappearance,  but  also  because  of  temporary  particle  dis-
appearance, e.g., due to Q-dot blinking. Thus, in the second step, the 
algorithm generated complete particle trajectories by linking the ends and 
starts of the track segments from the first step to close gaps resulting from 
temporary particle disappearance. In this step, all track segments were al-
lowed to compete with each other, resulting in a spatially and temporally 
global solution, adding stability to the tracker under high receptor density 
conditions. The cost functions used to weigh competing particle and track 
segment assignments were based on distance and intensity. All movies 
were analyzed using the same tracking parameters.
Microelastic mapping by atomic force microscopy
All force measurements were obtained using a Bioscope scanning-probe 
system (Digital Instruments) equipped with an extended range “J” scanner. 
This system was integrated with a confocal microscope (Fluoview 500; 
Olympus) and was controlled by a Nanoscope IIIA controller (Digital Instru-
ments) using version 4.49r3 of the software. Cells were probed with 200-µm 
triangular silicon nitride cantilevers (Veeco) with an approximate spring 
constant of 0.06 N/m.
Force curve data were acquired by making single measurements at 
multiple sites on individual cells, as defined by the experimenter. All mea-
surements were made in contact mode AFM with a scan rate of 1 Hz and 
a relative deflection set point of 20 nm. Reference force curve data points 
were acquired by making measurements against glass tissue culture dishes. 
At least four cells per condition per experiment were tested. Analysis of 
force curve data was performed using SPMCON-Nanoscope force curve 
analysis software.
Total internal reflection fluorescence microscopy (TIR-FM)
RAW macrophages stably expressing a GPI-linked GFP were scraped into 
1 ml of HPMI and incubated for 10 min at 37°C. Coverslips used in these 
experiments had previously been incubated in a solution of 1% (wt/vol) 
BSA for 1 h and washed. Individual coverslips were placed in a Leiden 
chamber with warm HPMI and then placed in a microscope stage heater 
set to 37°C. Cells were added and contact of the plasma membrane with 
the coverslip was imaged by TIR-FM microscopy using an inverted fluores-
cence microscope (Axiovert 200M; Carl Zeiss, Inc.) outfitted with a TIR-FM 
slider, a 100x objective (NA 1.4), a 488 diode-pumped solid-state laser 
(Spectral Applied Research), and a back-thinned, electron multiplied and 
cooled charged-coupled device camera (Hamamatsu Photonics). ImageJ 
software (National Institutes of Health, Bethesda, MD) was used to deter-
mine the surface area of the contact zones.
Scanning electron microscopy (SEM)
RAW macrophages were cultured on 18-mm coverslips and beads were 
allowed to bind to them as described above, except that washing was per-
formed gently using PBS at room temperature, to image also loosely bound 
beads in drug-treated cells. Next, the cells were fixed with 2% (vol/vol) 
glutaraldehyde and processed for SEM using standard methods.JCB • VOLUME 191 • NUMBER 6 • 2010   1218
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